Your browser doesn't support javascript.
loading
Neuroimaging in psychedelic drug development: past, present, and future.
Wall, Matthew B; Harding, Rebecca; Zafar, Rayyan; Rabiner, Eugenii A; Nutt, David J; Erritzoe, David.
Afiliación
  • Wall MB; Invicro, London, UK. matthew.wall@imperial.ac.uk.
  • Harding R; Faculty of Medicine, Imperial College London, London, UK. matthew.wall@imperial.ac.uk.
  • Zafar R; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK. matthew.wall@imperial.ac.uk.
  • Rabiner EA; Clinical Psychopharmacology Unit, Faculty of Brain Sciences, University College London, London, UK.
  • Nutt DJ; Faculty of Medicine, Imperial College London, London, UK.
  • Erritzoe D; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK.
Mol Psychiatry ; 28(9): 3573-3580, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37759038
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alucinógenos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alucinógenos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article